微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 42.32% | 0.5% | 8.23% | 84/130 | 51.33% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 39.1% | -7.56% | -7.14% | 91/130 | 52.41% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 42.11% | -15.53% | 3.16% | 88/130 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 40.82% | -22.22% | -3.06% | 91/130 | 53.59% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 42.11% | -18.22% | -0.45% | 84/130 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 42.3% | -43.44% | -15.15% | 89/130 | 53.39% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 49.85% | -34.33% | -5.01% | 72/130 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 52.48% | -31.55% | 1.92% | 68/130 | 53.53% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 51.49% | -33.94% | -31.14% | 71/130 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 74.78% | 14.27% | -1.49% | 17/130 | 53.92% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 75.92% | 29.27% | -0.99% | 15/130 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 76.67% | 29.13% | -1.64% | 13/130 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 77.95% | 2% | 19.11% | 14/130 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 65.44% | -13.79% | 11.44% | 49/130 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 58.73% | 2% | -1.09% | 61/130 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 59.37% | -23.91% | -21.79% | 63/130 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 75.91% | 48.14% | -2.72% | 26/130 | 59.67% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 78.03% | 2% | 52.28% | 24/130 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 51.24% | 1.29% | 1.29% | 69/130 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 50.59% | -3.63% | -3.63% | 62/130 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 52.49% | 2% | 2% | 57/130 | 55.34% | 正海生物 | 94.38% | 行业排名> |